Trial Profile
A case control study to compare the efficacy of detrusor injections of onabotulinum toxin A versus abobotulinum toxin A in patients with neurogenic detrusor overactivity
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Aug 2015
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Detrusor instability
- Focus Adverse reactions; Therapeutic Use
- 19 Aug 2015 New trial record